- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00876746
Optimization of Catheter Insertion Site for Continuous Peripheral Nerve Blocks
June 14, 2010 updated by: University of California, San Diego
This research study is to determine if the insertion site of a perineural catheter or tiny tube placed next to the nerves that go to the part of the body (hand or arm) having surgery, affects the amount of pain relief that is experienced after surgery.
Catheters will be placed in either the supraclavicular or infraclavicular location.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
To determine if a particular perineural local anesthetic catheter location (supraclavicular or infraclavicular) will maximize postoperative analgesia, minimize oral opioid requirements, minimize sleep disturbances resulting from postoperative pain, and maximize patient satisfaction.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Diego, California, United States, 92103
- UCSD Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years of age or older
- unilateral, upper (at or distal to the elbow) extremity orthopedic surgery with moderate-to-severe postoperative pain expected
- patients already agree to and want a continuous brachial plexus block for postoperative analgesia
Exclusion Criteria:
- patients who have difficulty understanding the study protocol or caring for the infusion pump/catheter system
- patients who have any known contraindication to study medications
- insulin-dependent diabetes mellitus
- neuropathy of any etiology in the affected extremity
- contraindication to regional blockade (e.g. clotting deficiency)
- any known acute or chronic hepatic or renal insufficiency or failure
- any incision site outside of the catheter-effected area
- chronic opioid use
- history of opioid abuse
- obesity
- pregnancy
- incarceration
- inability to communicate with the investigators and hospital staff
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 1. Supraclavicular
Patients will be randomized to placement of a nerve block in the supraclavicular position.
After the catheter has been placed, sensory and motor deficit will be assessed and following surgery, for the next three days, the patient will be contacted by research staff to assess pain scores and other outcome measures.
|
Patients will be randomized to one of two groups: nerve blocks in the supraclavicular location or the infraclavicular location.
Following surgery the patient will be called by study staff to assess pain scores, sleep disturbances, infusion side effects, feeling in fingers and other study outcomes.
|
|
Active Comparator: 2. Infraclavicular
Patients will be randomized to placement of a nerve block in the infraclavicular position.
After the catheter has been placed, sensory and motor deficit will be assessed and following surgery, for the next three days, the patient will be contacted by research staff to assess pain scores and other outcome measures.
|
Patients will be randomized to one of two groups: nerve blocks in the supraclavicular location or the infraclavicular location.
Following surgery the patient will be called by study staff to assess pain scores, sleep disturbances, infusion side effects, feeling in fingers and other study outcomes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Surgical pain as measured on a 0-10 scale where 0=no pain and 10=worst imaginable pain. The values for the two different catheter locations will be compared to see which site is optimal for catheter placement.
Time Frame: 3 days
|
3 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Opioids consumed by patient each day after surgery as reported to study staff.
Time Frame: 3 days
|
3 days
|
|
Sleeping disturbances (difficulty sleeping and awakenings due to pain) as reported to the study staff.
Time Frame: 3 days
|
3 days
|
|
Infusion side effects (shortness of breath) as reported to study staff.
Time Frame: 3 day
|
3 day
|
|
Satisfaction with pain control as measured on a 0-10 scale where 0=very unsatisfied and 10=very satisfied, as reported to study staff at time of daily phone calls
Time Frame: 3 days
|
3 days
|
|
Sensory and motor deficits (ability to move fingers and numbness of fingers) as reported to study staff.
Time Frame: 3 days
|
3 days
|
|
Catheter site discomfort, leakage at catheter site, and catheter related pain on the 0-10 rating scale, where 0=no pain and 10=worst imaginable pain, as reported to study staff during phone calls.
Time Frame: 3 days
|
3 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2008
Primary Completion (Actual)
January 1, 2010
Study Completion (Actual)
January 1, 2010
Study Registration Dates
First Submitted
April 3, 2009
First Submitted That Met QC Criteria
April 6, 2009
First Posted (Estimate)
April 7, 2009
Study Record Updates
Last Update Posted (Estimate)
June 15, 2010
Last Update Submitted That Met QC Criteria
June 14, 2010
Last Verified
April 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Supra / Infra Catheters
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.